Skip to main content
. 2018 Mar 25;9(5):516–522. doi: 10.1111/1759-7714.12598

Table 5.

Immunohistochemistry analysis of signal transducer and activator of transcription 3 and phosphorylated signal transducer and activator of transcription 3 proteins expression in non‐small cell lung cancer samples

Characteristics STAT3 χ2 P‐value pSTAT3 χ2 P‐value
(+) (−) (+) (−)
Gender
Male 15 11 0.120 0.729 12 14 0.742 0.389
Female 15 9 14 10
Age (years)
≤60 16 15 2.391 0.122 15 16 0.427 0.514
>60 14 5 11 8
Histological type
SCC 15 6 1.970 0.160 12 9 0.384 0.536
ADC 15 14 14 15
Differentiation
Well + moderate 13 18 11.092 0.001 10 21 12.738 0.000
Poor 17 2 16 3
pTNM
IA 7 13 8.750 0.013 5 15 12.139 0.002
IB 15 5 12 8
II 8 2 9 1
pSTAT3
Positive 23 3 18.283 0.000
Negative 7 17
MUC1
Positive 18 1 15.407 0.000 14 5 5.773 0.016
Negative 12 19 12 19
Total 30 20 26 24

ADC, adenocarcinoma; MUC1, mucin 1; NSCLC, non‐small cell lung cancer; pSTAT3, phosphorylated signal transducer and activator of transcription 3; pTNM, pathological TNM; SCC, squamous cell carcinoma; STAT3, signal transducer and activator of transcription 3.